Hims & Hers Health Stock News & Updates
[WKN: A2QMYY | Symbol: HIMS]
Hims & Hers – The US Telemedicine Provider Raises Forecast but Still Falls!
Hims significantly raises its revenue forecast – yet the stock still falls. The culprit is a loss of...
Hims & Hers – Revenue Rocket, Earnings Crash Landing: I Remain Skeptical and Await Proof!
I currently see two companies in Hims & Hers: an impressive growth story and a painful construction...
US Markets in Consolidation Mode – Geopolitical Shock Drives Oil Prices After Trump's Hormuz Blockade – Microsoft Attacks Nvidia's Dominance with New Maia 300 – Nvidia Plans $500 Billion Revolution for AI Infrastructure – Rocket Lab Ignites Revenue Rocket and Forges Galactic Empire – TSMC Crushes Expectations Thanks to Insatiable AI Hunger – Intel Shocks Investors with $15 Billion Capital Increase – Hims & Hers Plummets Despite Raised Forecast – AST SpaceMobile Reaches for the Stars with Japanese Billion Project
After the latest trading day on Monday, August 10, 2026, US markets were in a slight consolidation phase....
The Wall Street recovers after the $800 billion sell-off of the Magnificent Seven, while Brent falls back below the $100 mark and the oil shock loses its edge – Intel disproves the thesis of being an AI loser with the strongest growth since 2011, and NVIDIA secures Amkor's packaging capacity with an advance payment of $1.5 billion, while the DAX finds its way back toward 25,000 points thanks to a surge in SAP shares
USA & MACRO-ENVIRONMENT Wall Street struggles for stabilization, and it achieves it – albeit...
Hims & Hers – I Don’t Believe an 8-to-6 Majority Can Deliver $2.2 Billion!
I consider the enthusiasm surrounding Hims & Hers to be premature. Eight votes in favor against six...
Hims & Hers – The US Telemedicine Provider is Carried by a Narrow FDA Recommendation!
An 8-to-6 recommendation is not an approval. FDA advisors are opening peptides like BPC-157 for pharmacy...
Hims & Hers – Here's why I Expect a Short Squeeze!
Hims & Hers Health (HIMS, i) has a short-selling rate of about 28.4%, making it one of the most shorted...
Trump Invites US Corporations to China Summit - Hopes for Iran Deal Dwindle After Trump's Sharp Criticism - Lumentum in Nasdaq-100 - Constellation Energy in Regulatory Holding Pattern - Hims & Hers Slides After Weak Quarter
The US markets wrapped up the start of the new trading week on Monday, May 11, 2026, with moderate gains,...
Pivotal-Point Tracking Hims & Hers Health (HIMS): Frontrunner Position in the Peptide Market Secured by U.S. Authorities' Relaxation!
Hims & Hers operates a modern telemedicine platform that provides patients with access to personalized...
Hims & Hers: How Summer Massively Boosts the Business
Hims & Hers Health is a US telemedicine company specializing in digital health solutions around topics...
Hims & Hers: The Breakthrough is Imminent
For a long time, the stock of Hims & Hers was almost exclusively viewed as a speculative vehicle...